Pfizer Inc, an American multinational pharmaceutical corporation, has recently held talks with Allegran Plc to discuss takeover deal, which could be the biggest acquisition of this year, the Wall Street Journal and Financial Times reported.
The healthcare sector has seen several big and...read more
Market analysts believe that Pfizer's Ibrance, the first in a new class of cancer medicines, appears all poised for approval to treat advanced breast cancer in just a span of few months and at this pace it could soon become a blockbuster drug.
On Thursday, as the analysts' forecast was...read more
Pharmaceutical major Pfizer has announced that the Drug Application (NDA) for Palbociclib has been accepted for filing and has also been granted Priority Review by the United States Food and Drug Administration (FDA).
Palbociclib is an investigational oral targeted agent that selectively...read more
Pfizer will have to shell out $35 million to settle the issue of illegally marketing an organ transplant drug for unapproved uses. The pharmaceutical company faced allegations from 42 states, including Mississippi, after its Wyeth Pharmaceuticals reportedly breached drug marketing policies....read more
The overall ‘asthma epidemic’ among children has...Read More
People in huge numbers gathered in the Mount Lofty...Read More
As New Year is approaching, people have already...Read More
Alzheimer’s disease, the commonest cause of...Read More
Cases of opioid abuse have been increasing and...Read More
In an announcement made on December 22, cable giant...Read More